# Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production

> **NCT03063645** · PHASE1 · COMPLETED · sponsor: **Cerecin** · enrollment: 17 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AC-1202
- **DRUG:** AC-SD-01 (50 g)
- **DRUG:** AC-SD-01 (75 g)

## Key facts

- **NCT ID:** NCT03063645
- **Lead sponsor:** Cerecin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-11
- **Primary completion:** 2017-04-07
- **Final completion:** 2017-05-05
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03063645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03063645, "Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03063645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*